MED30 Antikörper (AA 29-105)
Kurzübersicht für MED30 Antikörper (AA 29-105) (ABIN7570234)
Target
Alle MED30 Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
-
-
Bindungsspezifität
- AA 29-105
-
Verwendungszweck
- Anti-Human MED30 Polyclonal Antibody
-
Aufreinigung
- Antigen affinity purification.
-
Immunogen
- E. coli - derived recombinant Human MED30 (Asn29-Gly105).
-
Isotyp
- IgG
-
-
-
-
Applikationshinweise
- Optimal working dilution should be determined by the investigator.
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Liquid
-
Buffer
- 0.01M PBS, pH 7.4, 50 % glycerol, 0.05 % Proclin 300.
-
Konservierungsmittel
- ProClin
-
Vorsichtsmaßnahmen
- This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Lagerung
- 4 °C,-20 °C,-80 °C
-
Informationen zur Lagerung
- Use a manual defrost freezer and avoid repeated freeze thaw cycles.Store at 4°C for frequent use.Store at -20 to -80 °C for twelve months from the date of receipt.
-
-
- MED30 (Mediator Complex Subunit 30 (MED30))
-
Andere Bezeichnung
- MED30
-
Hintergrund
- MED30, THRAP6, Mediator complex subunit 30, Thyroid hormone receptor-associated protein 6, TRAP25, TRAP/Mediator complex component TRAP25, Trap25, Mediator of RNA polymerase II transcription subunit 30, Thyroid hormone receptor-associated protein complex 25 kDa component
-
UniProt
- Q96HR3
-
Pathways
- Intracellular Steroid Hormone Receptor Signaling Pathway, Nuclear Hormone Receptor Binding, Stem Cell Maintenance, Regulation of Lipid Metabolism by PPARalpha
Target
-